Pharmacokinetics of a New Neuroprotector — Indenoquinoxalinone Derivative after Intravenous Administration in Rabbits and Rats
Bulletin of Experimental Biology and Medicine · 2023
DOI: 10.1007/s10517-023-05943-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bulletin of Experimental Biology and Medicine, 2023. Verfasst von E A Yanovskaya und 5 weiteren Autor:innen. Beteiligte Einrichtung: E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences, Tom…. Hauptthemen laut MEDLINE: Liver. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 11 Literaturangaben.
Abstract (Originalsprache)
The specific JNK inhibitor and NO donor 11H-indeno[1,2-b]quinoxalin-11-one oxime (IQ-1) demonstrated pronounced neuroprotective properties in an in vivo model of ischemic stroke in rats. The pharmacokinetic behavior of IQ-1 was studied in two animal species (rats, rabbits) after intravenous administration in a dose of 1 mg/kg. IQ-1 concentrations in venous blood plasma were measured by the liquid chromatography-tandem mass spectrometry method. The pharmacokinetics of IQ-1 was adequately described by the two-compartmental model. The calculated C0 for IQ-1 in rabbit and rat plasma were 2239.83±1229.55 and 1552.50±182.23 ng/ml, respectively. Two animal species are characterized by extensive tissue distribution of IQ-1 (Vss exceeded the total body water in rabbits and rats by 3.6 and 5.6 times, respectively) and high clearance values (88-94% of hepatic blood flow).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia. elena.yanovskaya@pharmso.ru.
- E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia.
- National Research Tomsk Polytechnic University, Tomsk, Russia.
Zitieren
APA
Yanovskaya, E. A., Frelikh, G. A., Lakeev, A. P., Chernysheva, G. A., Smol'yakova, V. I., & Kovrizhina, A. R. (2023). Pharmacokinetics of a New Neuroprotector — Indenoquinoxalinone Derivative after Intravenous Administration in Rabbits and Rats. Bulletin of Experimental Biology and Medicine. https://doi.org/10.1007/s10517-023-05943-7
Vancouver
Yanovskaya EA, Frelikh GA, Lakeev AP, Chernysheva GA, Smol'yakova VI, Kovrizhina AR. Pharmacokinetics of a New Neuroprotector — Indenoquinoxalinone Derivative after Intravenous Administration in Rabbits and Rats. Bulletin of Experimental Biology and Medicine. 2023. doi:10.1007/s10517-023-05943-7
BibTeX
@article{Yanovskaya2023,
author = {Yanovskaya, E A and Frelikh, G A and Lakeev, A P and Chernysheva, G A and Smol'yakova, V I and Kovrizhina, A R},
title = {Pharmacokinetics of a New Neuroprotector — Indenoquinoxalinone Derivative after Intravenous Administration in Rabbits and Rats},
journal = {Bulletin of Experimental Biology and Medicine},
year = {2023},
doi = {10.1007/s10517-023-05943-7}
}
EUVIMED